Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
AstraZeneca
Merck
McKesson
Baxter

Last Updated: December 7, 2021

DrugPatentWatch Database Preview

Patent: 6,114,603

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 6,114,603
Title: Genetic engineering of sugarbeet plants
Abstract:Methods for the transformation of sugarbeet which include the use of cyclical regeneration of the target plant and particle bombardment. Such methods allow for genotype-independent transformation. These methods further allow for a stably transformed sugarbeet plant. Plants produced in accordance with these methods are provided as well.
Inventor(s): Christou; Paul (Norwich, GB), Pelica; Fatima (Bowthorpe, GB)
Assignee: John Innes Center (Norwich, GB)
Application Number:09/049,142
Patent Claims:see list of patent claims

Details for Patent 6,114,603

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 1986-06-04 ⤷  Try it Free 2039-02-26
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Try it Free 2039-02-26
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Baxter
Boehringer Ingelheim
Merck
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.